India's Richest People 2026 edition · 1 director · Source: Hurun India
- #893 Postel Pascal & family ₹3,300 Cr
Princeps Pharmaceuticals Private Limited
Princeps Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Active Private Limited Company pharma
Revenue · FY 2024
₹7.24 Cr
▼ 32% YoY
Net profit · FY 2024
₹95.43 Lakh
Net margin 13.2%
EBITDA · FY 2024
₹1.19 Cr
EBITDA margin 16.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
26 yrs
Est. 2000
Employees · EPFO
1
Provident fund records
Directors on board
5
As per MCA filings
About Princeps Pharmaceuticals Private Limited
Data last updated:
Princeps Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 April 2000 and has been in existence for over 26 years.
Its director Postel Pascal and family are #893 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2000PTC073993. Its GSTIN is 19AACCP4921A1ZS (West Bengal). The company holds 12 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Dinesh Jain and Vitalapuram Rajangam Krishna Subramanian.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 55 Nelson Manickam Road Aminjikarai, Chennai, Tamil Nadu, India – 600029.
As per the financials filed for FY 2024, the company reported a revenue of ₹7.24 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹95.43 Lakh (net margin 13.2%) and EBITDA of ₹1.19 Cr (EBITDA margin 16.5%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 10% over five years.
The company has about 1 employee on its provident fund (EPFO) records.
Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230TN2000PTC073993
Registration Number 073993
Incorporation Date 13 April 2000
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
CIN history
Princeps Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230MH2000PTC125846. The current CIN is U24230TN2000PTC073993, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230TN2000PTC073993 | Current |
| U24230MH2000PTC125846 | Previous |
Key People
Errol James Desouza Additional Director Dinesh Jain Director Vitalapuram Rajangam Krishna Subramanian Director Recognitions & Rankings of Princeps Pharmaceuticals
Contact details
Princeps Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered Address55 Nelson Manickam Road Aminjikarai, Chennai, Tamil Nadu, India – 600029
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Princeps Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Princeps Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Princeps Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Princeps Pharmaceuticals Private Limited, buy the company report.
Financials of Princeps Pharmaceuticals Private Limited
FY 2024 filings availablePrinceps Pharmaceuticals Private Limited reported revenue of ₹7.24 Cr (down 32% YoY) for FY 2024.
Revenue · FY 2024
₹7.24 Cr ▼ 32%
Net profit · FY 2024
₹95.43 Lakh margin 13.2%
EBITDA · FY 2024
₹1.19 Cr margin 16.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
3 years · compounded
▲ 27%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 16%
5 years · compounded
▲ 31%
Revenue fell 32% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.19 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.5% | ||||
| Net Profit Margin | 13.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Princeps Pharmaceuticals Private Limited, buy the company report.
Board of directors of Princeps Pharmaceuticals Private Limited
Princeps Pharmaceuticals has 5 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Errol James Desouza Also directs: Franco Indian Medicare Pvt Ltd, Franco Indian Therapeutics Pvt. Ltd., Franco-Indian Pharmaceuticals Private Limited and 5 more | Additional Director | 15 Jan 2025 | 1 Years 9 Months | Current |
| Dinesh Jain | Director | 27 Jan 2018 | 8 Years 8 Months | Current |
| Vitalapuram Rajangam Krishna Subramanian Also directs: Wardex Pharmaceuticals Private Limited | Director | 29 Oct 2013 | 12 Years 11 Months | Current |
| Lalsa Balgovind Yadav Also directs: Franco Indian Medicare Pvt Ltd, Franco Indian Therapeutics Pvt. Ltd., Franco-Indian Pharmaceuticals Private Limited and 4 more | Director | 01 Sep 2007 | 19 Years 1 Months | Current |
| Pascal Postel Also directs: Franco Indian Medicare Pvt Ltd, Franco Indian Therapeutics Pvt. Ltd., Franco-Indian Pharmaceuticals Private Limited and 4 more | Director | 04 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Princeps Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meek Pharma Private Limited | ₹7.28 Cr (FY 2025) | 109.0% | Rudrapur, Uttarakhand, India | |||
| Princeps Pharmaceuticals Private Limitedthis company | ₹7.24 Cr (FY 2024) | ₹95.43 Lakh | 13.2% | -32.0% | 1 | Chennai, Tamil Nadu, India |
| Plethico Laboratories Pvt Ltd | ₹7.23 Cr (FY 2025) | 25.0% | Indore, Madhya Pradesh, India | |||
| Nikita Chemi-Intermediates Private Limited | ₹7.22 Cr (FY 2024) | Mumbai, Maharashtra, India | ||||
| Bhumi Petrochem Pvt Ltd | ₹7.22 Cr (FY 2025) | 100.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Princeps Pharmaceuticals Private Limited, buy the company report.
Auditor
Princeps Pharmaceuticals Private Limited is audited by MADLANI & VITHLANI for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MADLANI & VITHLANI | FY 2022 | 105722W |
Shareholding
The shareholding of Princeps Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Princeps Pharmaceuticals Private Limited, buy the company report.
Legal cases
Princeps Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Princeps Pharmaceuticals, 1 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (COMIP) | Filed by the company against Avizen Biopharma Private Limited and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed by the company against Prochem Pharmaceuticals (P) Ltd and 1 other | Pending |
| Bombay High Court | Court case (S) | Filed against the company by Franco Indian Pharmaceuticals Pvt. Ltd. and Anr | Disposed |
To see the full case history of Princeps Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Princeps Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Princeps Pharmaceuticals Private Limited has a workforce of 1 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
1
Active EPFO establishments
1
GST
Princeps Pharmaceuticals has 12 GST registrations: 1 active and 11 cancelled or inactive.
Total GSTINs
12
Active
1
Cancelled / inactive
11
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCP4921A1ZS | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Princeps Pharmaceuticals Private Limited, buy the company report.
Recent activity
Princeps Pharmaceuticals Private Limited has 16 board changes on record since 2007: 5 appointments and 11 cessations. The latest: Errol James Desouza was appointed as Additional Director on 15 Jan 2025.
Appointed
Errol James Desouza was appointed as Additional Director.
AGM
Princeps Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
Filing
Princeps Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Mohanchand Pradeep Dadha ceased to be Director.
Ceased
Anil Kumar Khanna ceased to be Director.
Ceased
Pascal Postel ceased to be Additional Director.
Ceased
Noel Christopher Amanna ceased to be Director.
Appointed
Pascal Postel was appointed as Director.
Ceased
Dinesh Jain ceased to be Additional Director.
Appointed
Dinesh Jain was appointed as Director.
Ceased
Lallan Prasad Gupta ceased to be Director.
Ceased
Errol James Desouza ceased to be Director.
7 earlier events are in the company report.
Frequently asked questions
Princeps Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 April 2000 (26+ years old) and is registered under CIN U24230TN2000PTC073993.
Princeps Pharmaceuticals has 5 current directors:
- Errol James Desouza - Additional Director
- Dinesh Jain - Director
- Vitalapuram Rajangam Krishna Subramanian - Director
- Lalsa Balgovind Yadav - Director
- Pascal Postel - Director
The latest financial statements of Princeps Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Princeps Pharmaceuticals is 19AACCP4921A1ZS, registered in West Bengal. The company has 12 GST registrations in all, of which 1 is active and 11 are cancelled or inactive.
The CIN (Corporate Identification Number) of Princeps Pharmaceuticals is U24230TN2000PTC073993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Princeps Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 2 are pending.
Princeps Pharmaceuticals was incorporated on 13 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Princeps Pharmaceuticals by revenue are Meek Pharma Private Limited, Plethico Laboratories Pvt Ltd, Nikita Chemi-Intermediates Private Limited, Bhumi Petrochem Pvt Ltd, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Errol James Desouza was appointed as Additional Director on 15 Jan 2025. Mohanchand Pradeep Dadha ceased to be Director on 21 Jan 2023. Anil Kumar Khanna ceased to be Director on 31 Mar 2022. Princeps Pharmaceuticals has 16 board changes on record in total.
The registered office of Princeps Pharmaceuticals is at 55 Nelson Manickam Road Aminjikarai, Chennai, Tamil Nadu, India – 600029.
Princeps Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.